[HEALTH.MIL] Laboratory Developed Tests Covered Under TRICARE Demonstration May Help Guide Cancer Treatment Decisions

From: HEALTH.MIL@xxxxxxxxxxxxx
To: <HEALTH.MIL@xxxxxxxxxxxxx>
Date: Tue, 31 Jul 2012 12:13:33 -0500

Laboratory Developed Tests Covered Under TRICARE Demonstration May Help Guide
Cancer Treatment Decisions

July 31, 2012
12-5

FALLS CHURCH, Va. - Some TRICARE beneficiaries will soon be able to take
advantage of new technologies aimed at helping patients and healthcare providers
make more informed decisions regarding treatment options for surgery,
chemotherapy or radiation therapy for some types of cancer.
 
On May 22, 2012, two laboratory developed tests were approved for coverage by
TRICARE under a demonstration project: the BRACAnalysis BRCA1 and BRCA2 tests
(Myriad Genetic Laboratories, Inc.), and also, the Oncotype DX Breast Cancer
Assay (Genomic Health, Inc.).
 
BRACAnalysis testing assesses a woman's risk of developing hereditary breast or
ovarian cancers based on detection of mutations in their BRCA1 and BRCA2 genes.
The Oncotype DX breast cancer assay is a test that examines a breast cancer
patient's tumor tissue at the molecular level; specifically, it is hoped that
this information can help individualize the planning of the patient's breast
cancer treatment. The complete description of this demonstration project is
available at www.gpo.gov/fdsys/pkg/FR-2011-12-27/html/2011-33066.htm.
 
The criteria for which of these tests will be covered by TRICARE are scheduled
to be published in the TRICARE Operations Manual in August 2012. TRICARE
providers will be prepared to accept patients under the demonstration project by
September 30, 2012; however, coverage for the approved use of these tests is
retroactive to May 22, 2012. Beneficiaries should speak with their primary
health care professional or their regional contractor to determine their
eligibility for having these tests performed as a TRICARE benefit.  Find
regional contractor contact information at www.tricare.mil/contactus.






== HEALTH.MIL Mailing List ==

1.  The following options may be used to join\leave this mailing list:

    a.  ONLINE OPTION:  Online subscription\unsubscription options are 
available at:

        http://www.hostmtb.org
        http://www.hostmtb.org/hmil.html
        //www.freelists.org/list/health.mil

    b.  E-MAIL OPTION:  Subscription\unsubscription may be performed by sending 
an E-Mail message to the following address:

        (1)  To subscribe to this mailing list, send an E-Mail message to 
HEALTH.MIL-request@xxxxxxxxxxxxx with 'subscribe' as the subject.

        (2)  To unsubscribe, send an E-Mail message to 
HEALTH.MIL-request@xxxxxxxxxxxxx with 'unsubscribe' as the subject.

2.  If the above subscribe or unsubscribe procedures don't work or if you have 
questions, comments, etc., about this mailing list, please contact 
Milton.Bell126@xxxxxxxxx

[HEALTH.MIL] Laboratory Developed Tests Covered Under TRICARE Demonstration May Help Guide Cancer Treatment Decisions

Other related posts: